Citations (88)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Jens F. Rehfeld, Kasper Broedbaek, Jens P. Goetze, Ulrich Knigge & Linda M. Hilsted. (2020) True Chromogranin A concentrations in plasma from patients with small intestinal neuroendocrine tumours. Scandinavian Journal of Gastroenterology 55:5, pages 565-573.
Read now
Read now
Lingaku Lee, Tetsuhide Ito & Robert T. Jensen. (2018) Everolimus in the treatment of neuroendocrine tumors: efficacy, side-effects, resistance, and factors affecting its place in the treatment sequence. Expert Opinion on Pharmacotherapy 19:8, pages 909-928.
Read now
Read now
Bengt Glimelius. (2016) Tell all the good news as soon as possible. Acta Oncologica 55:9-10, pages 1067-1068.
Read now
Read now
Jorma Heikkonen, Hanna Mäenpää, Eero Hippeläinen, Vappu Reijonen & Mikko Tenhunen. (2016) Effect of calculation method on kidney dosimetry in 177Lu-octreotate treatment. Acta Oncologica 55:9-10, pages 1069-1076.
Read now
Read now
Knut Jørgen Labori, Sven-Petter Haugvik & Pål-Dag Line. (2016) Letter to the editor: Multidisciplinary management of pancreatic neuroendocrine tumors – the importance of an aggressive surgical approach. Scandinavian Journal of Gastroenterology 51:3, pages 383-384.
Read now
Read now
Elizaveta Mitkina Tabaksblat, Seppo W. Langer, Ulrich Knigge, Henning Grønbæk, Jann Mortensen, René Horsleben Petersen, Birgitte Hartnack Federspiel & Morten Ladekarl. (2016) Diagnosis and treatment of bronchopulmonary neuroendocrine tumours: State of the art. Acta Oncologica 55:1, pages 3-14.
Read now
Read now
Andreas Kjaer & Ulrich Knigge. (2015) Use of radioactive substances in diagnosis and treatment of neuroendocrine tumors. Scandinavian Journal of Gastroenterology 50:6, pages 740-747.
Read now
Read now
Eva Tiensuu Janson. (2014) Treatment with somatostatin analogues may delay progression of neuroendocrine tumours. Acta Oncologica 53:10, pages 1283-1283.
Read now
Read now
Articles from other publishers (80)
Karen Kristina Nyvold Johnson, Tobias Stemann Lau, Simon Mark Dahl Baunwall, Gerda Elisabeth Villadsen, Vibeke Guldbrand Rasmussen, Henning Grønbæk, Riina Karoliina Oksjoki & Gitte Dam. (2023) The role of N‐terminal pro‐brain natriuretic peptide, chromogranin A, and 5‐hydroxyindoleacetic acid in screening for carcinoid heart disease. Journal of Neuroendocrinology 35:10.
Crossref
Crossref
Satoshi Komiyama, Takuji Okusaka, Yuta Maruki, Akihiro Ohba, Yoshikuni Nagashio, Shunsuke Kondo, Susumu Hijioka, Chigusa Morizane, Hideki Ueno, Aoi Sukeda, Takahiro Mizui, Takeshi Takamoto, Satoshi Nara, Daisuke Ban, Minoru Esaki, Nobuyoshi Hiraoka & Kazuaki Shimada. (2023) Clinicopathological Findings and Treatment Outcomes of Patients with Primary Hepatobiliary Neuroendocrine Neoplasms: A Retrospective Single-institution Analysis. Internal Medicine.
Crossref
Crossref
Mu‐Xing Li, Alexandra G. Lopez‐Aguiar, George Poultsides, Flavio Rocha, Sharon Weber, Ryan Fields, Kamran Idrees, Cliff Cho, Shishir K. Maithel, Xu‐Feng Zhang & Timothy M. Pawlik. (2022) Surgical outcomes of gastro‐entero‐pancreatic neuroendocrine tumors G3 versus neuroendocrine carcinoma. Journal of Surgical Oncology 126:4, pages 689-697.
Crossref
Crossref
Jisheng ZhuWeidong XiaoYong Li. (2022) Management of Primary Hepatopancreatobiliary and Ampulla Large Cell Neuroendocrine Carcinoma. Journal of Laparoendoscopic & Advanced Surgical Techniques 32:6, pages 639-645.
Crossref
Crossref
Naoko Fukushima, Kenei Furukawa, Yuta Takano, Toshiaki Suzuki, Mitsuyama Yoshinobu, Ken Hanyu & Susumu Kobayashi. (2022) Multiple large cell neuroendocrine carcinomas in the rectum and descending colon presented with liver metastasis: A case report. Asian Journal of Endoscopic Surgery 15:2, pages 405-409.
Crossref
Crossref
Lingaku Lee, Irene Ramos-Alvarez & Robert T. Jensen. (2022) Predictive Factors for Resistant Disease with Medical/Radiologic/Liver-Directed Anti-Tumor Treatments in Patients with Advanced Pancreatic Neuroendocrine Neoplasms: Recent Advances and Controversies. Cancers 14:5, pages 1250.
Crossref
Crossref
Jon Arne Søreide, Jan Terje Kvaløy, Dordi Lea, Oddvar M. Sandvik, Mohammed Al‐Saiddi, Torjan M. Haslerud, Herish Garresori, Lars N. Karlsen, Einar Gudlaugsson & Kjetil Søreide. (2021) The overriding role of surgery and tumor grade for long‐term survival in patients with gastroenteropancreatic neuroendocrine neoplasms: A population‐based cohort study. Cancer Reports 5:2.
Crossref
Crossref
Taro Kogami, Tomohisa Iwai, Mitsuhiro Kida, Kosuke Okuwaki, Rikiya Hasegawa, Takahiro Kurosu, Masafumi Watanabe, Masahiro Matsushita, Kana Imawari, Kai Adachi, Masayoshi Tadehara, Akihiro Tamaki, Hiroshi Imaizumi & Wasaburo Koizumi. (2021) A case of pancreatic neuroendocrine carcinoma with a favorable clinical response to pembrolizumab. Clinical Journal of Gastroenterology 14:6, pages 1804-1810.
Crossref
Crossref
Min-Young Do, Sung-Ill Jang, Hua-Pyong Kang, Eui-Joo Kim, Kyong-Joo Lee, Go-Eun Park, Su-Jee Lee, Dong-Ki Lee, Sang-Myung Woo & Jae-Hee Cho. (2021) Comparison of the Clinical Features and Outcomes of Gallbladder Neuroendocrine Carcinoma with Those of Adenocarcinoma: A Propensity Score-Matched Analysis. Cancers 13:18, pages 4713.
Crossref
Crossref
Anita Michael & Debashis K Nath. (2021) Neoadjuvant and Adjuvant Chemotherapeutic Strategy of Colorectal Mixed Adeno-Neuroendocrine Carcinomas. Cureus.
Crossref
Crossref
Christopher Millet, Alisa Farokhian, Nader Mekheal, Balraj Singh & Walid Baddoura. (2021) Massive Mixed Adenoneuroendocrine Carcinoma: A Case Report. Cureus.
Crossref
Crossref
Tina Binderup, Ulrich Knigge, Camilla Bardram Johnbeck, Annika Loft, Anne Kiil Berthelsen, Peter Oturai, Jann Mortensen, Birgitte Federspiel, Seppo W. Langer & Andreas Kjaer. (2021)
18
F-FDG PET is Superior to WHO Grading as a Prognostic Tool in Neuroendocrine Neoplasms and Useful in Guiding PRRT: A Prospective 10-Year Follow-up Study
. Journal of Nuclear Medicine 62:6, pages 808-815.
Crossref
Crossref
Santiago Teran, Maria Camara Jurado & Juan Antonio Nuñez Sobrino. (2021) A Patient with an Ileocecal MiNEN and a Synchronous Squamous Non-Small-Cell Lung Cancer: Case Report and Review of the Literature. Case Reports in Oncological Medicine 2021, pages 1-8.
Crossref
Crossref
Mathias Loft, Camilla B. Johnbeck, Esben A. Carlsen, Helle H. Johannesen, Peter Oturai, Seppo W. Langer, Ulrich Knigge & Andreas Kjaer. (2021) Initial Experience with 64Cu-DOTATATE Digital PET of Patients with Neuroendocrine Neoplasms: Comparison with Analog PET. Diagnostics 11:2, pages 350.
Crossref
Crossref
Mathias Loft, Esben A. Carlsen, Camilla B. Johnbeck, Helle H. Johannesen, Tina Binderup, Andreas Pfeifer, Jann Mortensen, Peter Oturai, Annika Loft, Anne K. Berthelsen, Seppo W. Langer, Ulrich Knigge & Andreas Kjaer. (2021)
64
Cu-DOTATATE PET in Patients with Neuroendocrine Neoplasms: Prospective, Head-to-Head Comparison of Imaging at 1 Hour and 3 Hours After Injection
. Journal of Nuclear Medicine 62:1, pages 73-80.
Crossref
Crossref
Magnus Kjellman, Ulrich Knigge, Staffan Welin, Espen Thiis-Evensen, Henning Gronbaek, Camilla Schalin-Jäntti, Halfdan Sorbye, Maiken Thyregod Joergensen, Viktor Johanson, Saara Metso, Helge Waldum, Jon Arne Søreide, Tapani Ebeling, Fredrik Lindberg, Kalle Landerholm, Goran Wallin, Farhad Salem, Maria del Pilar Schneider & Roger Belusa. (2021) A Plasma Protein Biomarker Strategy for Detection of Small Intestinal Neuroendocrine Tumors. Neuroendocrinology 111:9, pages 840-849.
Crossref
Crossref
Tingsong Yang, Zhilong Ma, Jie Hua, Zhenshun Song, Jiajie Zhang, Xiaoyi Wang & Deliang Fu. 2021. Integrative Pancreatic Intervention Therapy. Integrative Pancreatic Intervention Therapy
181
224
.
Abir Salwa Ali, Seppo W. Langer, Birgitte Federspiel, Geir Olav Hjortland, Henning Grønbæk, Morten Ladekarl, Staffan Welin, Lene Weber Vestermark, Johanna Arola, Pia Osterlund, Ulrich Knigge, Halfdan Sørbye, Patrick Micke, Lars Grimelius, Malin Grönberg & Eva Tiensuu Janson. (2020) PD-L1 expression in gastroenteropancreatic neuroendocrine neoplasms grade 3. PLOS ONE 15:12, pages e0243900.
Crossref
Crossref
Kunihiko Suga, Hiroomi Ogawa, Makoto Sohda, Chika Katayama, Naoya Ozawa, Katsuya Osone, Takuhisa Okada, Takuya Shiraishi, Ryuji Katoh, Akihiko Sano, Makoto Sakai, Takehiko Yokobori, Ken Shirabe & Hiroshi Saeki. (2020) A case of colorectal large cell neuroendocrine carcinoma accompanied by disseminated peritoneal leiomyomatosis. Surgical Case Reports 6:1.
Crossref
Crossref
Halfdan Sorbye, Liv Sylvi Meyer, Kjersti Elisabeth Mordal, Simen Myhre & Espen Thiis-Evensen. (2020) Patient reported symptoms, coping and quality of life during somatostatin analogue treatment for metastatic small- intestinal neuroendocrine tumours. Health and Quality of Life Outcomes 18:1.
Crossref
Crossref
Jonas Baekdal, Jesper Krogh, Marianne Klose, Pernille Holmager, Seppo W. Langer, Peter Oturai, Andreas Kjaer, Birgitte Federspiel, Linda Hilsted, Jens F. Rehfeld, Ulrich Knigge & Mikkel Andreassen. (2020) Limited Diagnostic Utility of Chromogranin A Measurements in Workup of Neuroendocrine Tumors. Diagnostics 10:11, pages 881.
Crossref
Crossref
Jayne Palmer & Oscar R Leeuwenkamp. (2020)
Cost-effectiveness of lutetium (
177
Lu) oxodotreotide
vs
everolimus in gastroenteropancreatic neuroendocrine tumors in Norway and Sweden
. World Journal of Clinical Cases 8:20, pages 4793-4806.
Crossref
Crossref
Esben Andreas Carlsen, Camilla Bardram Johnbeck, Tina Binderup, Mathias Loft, Andreas Pfeifer, Jann Mortensen, Peter Oturai, Annika Loft, Anne Kiil Berthelsen, Seppo W. Langer, Ulrich Knigge & Andreas Kjaer. (2020)
64
Cu-DOTATATE PET/CT and Prediction of Overall and Progression-Free Survival in Patients with Neuroendocrine Neoplasms
. Journal of Nuclear Medicine 61:10, pages 1491-1497.
Crossref
Crossref
Rani Kanthan, Suresh Tharmaradinam, Tehmina Asif, Shahid Ahmed & Selliah C Kanthan. (2020) Mixed epithelial endocrine neoplasms of the colon and rectum – An evolution over time: A systematic review. World Journal of Gastroenterology 26:32, pages 5181-5206.
Crossref
Crossref
Abir Salwa Ali, Aurel Perren, Cecilia Lindskog, Staffan Welin, Halfdan Sorbye, Malin Grönberg & Eva Tiensuu Janson. (2020) Candidate protein biomarkers in pancreatic neuroendocrine neoplasms grade 3. Scientific Reports 10:1.
Crossref
Crossref
Jie-ying Zhao, Hua Zhuang, Yuan Luo, Ming-gang Su, Mo-li Xiong & Yu-ting Wu. (2020) Double contrast-enhanced ultrasonography of a small intestinal neuroendocrine tumor: a case report of a recommendable imaging modality. Precision Clinical Medicine 3:2, pages 147-152.
Crossref
Crossref
Regis Souche, Antoine Coignac, Marie Dupuy, Martin Bertrand, Isabelle Raingeart, Boris Guiu, Astrid Herrero, Fabrizio Panaro, Stephane Obled, Fabienne Portales, Benjamin Riviere, Jeanne Ramos, Frederic Borie, Francois Quenet, Pierre-Emmanuel Colombo, Michel Prudhomme, Eric Assenat & Jean-Michel Fabre. (2020) Outcome after pancreatectomy for neuroendocrine neoplams according to the WHO 2017 grading system: A retrospective multicentric analysis of 138 consecutive patients. Clinics and Research in Hepatology and Gastroenterology 44:3, pages 286-294.
Crossref
Crossref
Burcin Özdirik, Anna Stueven, Jana Knorr, Lukas Geisler, Raphael Mohr, Münevver Demir, Teresa Hellberg, Sven H. Loosen, Fabian Benz, Bertram Wiedenmann, Frank Tacke, Alexander Wree, Henning Jann & Christoph Roderburg. (2020) Soluble Urokinase Plasminogen Activator Receptor (suPAR) Concentrations Are Elevated in Patients with Neuroendocrine Malignancies. Journal of Clinical Medicine 9:6, pages 1647.
Crossref
Crossref
Gitte Dam, Henning Grønbæk, Halfdan Sorbye, Espen Thiis Evensen, Björn Paulsson, Anders Sundin, Claus Jensen, Dyveke Ebbesen, Ulrich Knigge & Eva Tiensuu Janson. (2020) Prospective Study of Chromogranin A as a Predictor of Progression in Patients with Pancreatic, Small-Intestinal, and Unknown Primary Neuroendocrine Tumors. Neuroendocrinology 110:3-4, pages 217-224.
Crossref
Crossref
Xiaoxiao Jiao, Wenqing Luan, Xiaoqian Peng, Lu Liu, Lianfeng Zhang & Lin Zhou. (2020) Effects of tumor origins and therapeutic options on the prognosis of hepatic neuroendocrine tumors. Medicine 99:51, pages e23655.
Crossref
Crossref
Hirotaka Ishida & Alfred King-Yin Lam. (2020) Pancreatic neuroendocrine neoplasms: The latest surgical and medical treatment strategies based on the current World Health Organization classification. Critical Reviews in Oncology/Hematology 145, pages 102835.
Crossref
Crossref
Gunjan S. Desai, Prasad Pande, Verushka Chhabra, Rajiv C. Shah & Palepu Jagannath. (2019) Multimodality management, recurrence patterns, and long-term outcome of gastroenteropancreatic neuroendocrine neoplasms: Progress over 17 years. Indian Journal of Gastroenterology 38:5, pages 399-410.
Crossref
Crossref
Bianka Saravana-Bawan, Stella Koumna, Marguerite Wieler, Alexander McEwan & Todd McMullen. (2019) Comparison and clinical implementation of quality of life tools in patients with small bowel neuroendocrine tumors treated with Lu-DOTA-TATE PRRT. International Journal of Endocrine Oncology 6:2, pages IJE21.
Crossref
Crossref
Vincenzo Cuccurullo, Giuseppe Danilo Di Stasio & Luigi Mansi. (2019) Physiopathological Premises to Nuclear Medicine Imaging of Pancreatic Neuroendocrine Tumours. Current Radiopharmaceuticals 12:2, pages 98-106.
Crossref
Crossref
Sara Storvall, Eeva Ryhänen, Frank V Bensch, Ilkka Heiskanen, Soili Kytölä, Tapani Ebeling, Siru Mäkelä & Camilla Schalin‐Jäntti. (2018) Recurrent Metastasized Parathyroid Carcinoma—Long‐Term Remission After Combined Treatments With Surgery, Radiotherapy, Cinacalcet, Zoledronic Acid, and Temozolomide. JBMR Plus 3:4.
Crossref
Crossref
Levent Dizdar, Thomas A. Werner, Jasmin C. Drusenheimer, Birte Möhlendick, Katharina Raba, Inga Boeck, Martin Anlauf, Matthias Schott, Wolfgang Göring, Irene Esposito, Nikolas H. Stoecklein, Wolfram T. Knoefel & Andreas Krieg. (2018)
BRAF
V600E
mutation: A promising target in colorectal neuroendocrine carcinoma
. International Journal of Cancer 144:6, pages 1379-1390.
Crossref
Crossref
George A. Fisher. 2019. Textbook of Gastrointestinal Oncology. Textbook of Gastrointestinal Oncology
269
287
.
A. van der Veen, M.F.J. Seesing, B.P.L. Wijnhoven, W.O. de Steur, M.I. van Berge Henegouwen, C. Rosman, J.W. van Sandick, S. Mook, N. Haj Mohammad, J.P. Ruurda, L.A.A. Brosens, R. van Hillegersberg, Y.A. Alderlieste, P.C. Baas, E.J.T. Belt, C. Ünlü, J.W.D. de Waard, P. Duijvendijk, J. Heisterkamp, E.A. Kouwenhoven, G.A.P. Nieuwenhuijzen, E.G.J.M. Pierik, J.T.M. Plukker, A. Pronk, A.M. Rijken, J.J.G. Scheepers, J.H. Stoot, G.W.M. Tetteroo, G.J.D. van Acker, E. van der Harst & D.L. van der Peet. (2018) Management of resectable esophageal and gastric (mixed adeno)neuroendocrine carcinoma: A nationwide cohort study. European Journal of Surgical Oncology 44:12, pages 1955-1962.
Crossref
Crossref
Meng-jun Qiu, Yao-bing Chen, Ning-rui Bi, Sheng-li Yang, Xiao-xiao He & Zhi-fan Xiong. (2018) Comparative Clinical Analysis of Gastroenteropancreatic Neuroendocrine Carcinomas with Liver Metastasis and Primary Hepatic Neuroendocrine Carcinomas. Disease Markers 2018, pages 1-10.
Crossref
Crossref
Halfdan Sorbye, Eric Baudin & Aurel Perren. (2018) The Problem of High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms. Endocrinology and Metabolism Clinics of North America 47:3, pages 683-698.
Crossref
Crossref
Jang Jin Kim, Sung Su Park, Taek-Gu Lee, Ho-Chang Lee & Sang-Jeon Lee. (2018) Large Cell Neuroendocrine Carcinoma of the Colon With Carcinomatosis Peritonei. Annals of Coloproctology 34:4, pages 222-225.
Crossref
Crossref
Kristina Døssing, Christina Kjær, Jonas Vikeså, Tina Binderup, Ulrich Knigge, Michael Culler, Andreas Kjær, Birgitte Federspiel & Lennart Friis-Hansen. (2018) Somatostatin Analogue Treatment Primarily Induce miRNA Expression Changes and Up-Regulates Growth Inhibitory miR-7 and miR-148a in Neuroendocrine Cells. Genes 9:7, pages 337.
Crossref
Crossref
Zhonghua Wu, Dehao Yu, Shan Zhao, Peng Gao, Yongxi Song, Yu Sun, Xiaowan Chen & Zhenning Wang. (2018) The efficacy of chemotherapy and operation in patients with colorectal neuroendocrine carcinoma. Journal of Surgical Research 225, pages 54-67.
Crossref
Crossref
David R. Martin, Elisa LaBauve, Joseph M. Pomo, Vi K. Chiu, Joshua A. Hanson & Rama R. Gullapalli. (2018) Site-Specific Genomic Alterations in a Well-Differentiated Pancreatic Neuroendocrine Tumor With High-Grade Progression. Pancreas 47:4, pages 502-510.
Crossref
Crossref
Abir Salwa Ali, Malin Grönberg, Seppo W. Langer, Morten Ladekarl, Geir Olav Hjortland, Lene Weber Vestermark, Pia Österlund, Staffan Welin, Henning Grønbæk, Ulrich Knigge, Halfdan Sorbye & Eva Tiensuu Janson. (2018) Intravenous versus oral etoposide: efficacy and correlation to clinical outcome in patients with high-grade metastatic gastroenteropancreatic neuroendocrine neoplasms (WHO G3). Medical Oncology 35:4.
Crossref
Crossref
Guangjian Yang, Dan Li, Fangchao Zheng & Lin Yang. (2018) Long‑term disease free survival of gastric mixed adenoneuroendocrine carcinoma treated with multimodality therapy: A case report. Molecular and Clinical Oncology.
Crossref
Crossref
Kenta Kawasaki, Masayuki Fujii & Toshiro Sato. (2018) Gastroenteropancreatic neuroendocrine neoplasms: genes, therapies and models. Disease Models & Mechanisms 11:2.
Crossref
Crossref
Safak Gül-Klein, Marianne Sinn, Philipp Sebastian Jurmeister, Matthias Biebl, Sascha Weiß, Beate Rau, Hendrik Bläker, Johann Pratschke & Felix Aigner. (2018) Two patients with rare mixed adenoneuroendocrine carcinomas of the rectum. SAGE Open Medical Case Reports 6, pages 2050313X1875881.
Crossref
Crossref
Noora Karppinen, Riikka Lindén, Harri Sintonen, Maija Tarkkanen, Risto Roine, Ilkka Heiskanen, Niina Matikainen & Camilla Schalin-Jäntti. (2018) Health-Related Quality of Life in Patients with Small Intestine Neuroendocrine Tumors. Neuroendocrinology 107:4, pages 366-374.
Crossref
Crossref
Anna Pellat, Chantal Dreyer, Camille Couffignal, Thomas Walter, Catherine Lombard-Bohas, Patricia Niccoli, Jean François Seitz, Olivia Hentic, Thierry André, Romain Coriat, Sandrine Faivre, Magaly Zappa, Philippe Ruszniewski, Nicolas Pote, Anne Couvelard & Eric Raymond. (2018) Clinical and Biomarker Evaluations of Sunitinib in Patients with Grade 3 Digestive Neuroendocrine Neoplasms. Neuroendocrinology 107:1, pages 24-31.
Crossref
Crossref
Ulrich Knigge, Mikkel Andreassen, Birgitte Federspiel, Carsten Palnæs Hansen, Andreas Kjær & Seppo W. Langer. 2018. Encyclopedia of Endocrine Diseases. Encyclopedia of Endocrine Diseases
626
634
.
Maria Laura Del Basso De Caro, Elia Guadagno & Gaetano De Rosa. 2018. Neuroendocrine Tumors in Real Life. Neuroendocrine Tumors in Real Life
29
49
.
Stephan Petersenn & Christian A. Koch. (2018) Neuroendocrine neoplasms – still a challenge despite major advances in clinical care with the development of specialized guidelines. Reviews in Endocrine and Metabolic Disorders 18:4, pages 373-378.
Crossref
Crossref
Abir Salwa Ali, Malin Grönberg, Birgitte Federspiel, Jean-Yves Scoazec, Geir Olav Hjortland, Henning Grønbæk, Morten Ladekarl, Seppo W. Langer, Staffan Welin, Lene Weber Vestermark, Johanna Arola, Pia Österlund, Ulrich Knigge, Halfdan Sorbye, Lars Grimelius & Eva Tiensuu Janson. (2017) Expression of p53 protein in high-grade gastroenteropancreatic neuroendocrine carcinoma. PLOS ONE 12:11, pages e0187667.
Crossref
Crossref
R.B. Galleberg, U. Knigge, E. Tiensuu Janson, L.W. Vestermark, S.-P. Haugvik, M. Ladekarl, S.W. Langer, H. Grønbæk, P. Österlund, G.O. Hjortland, J. Assmus, L. Tang, A. Perren & H. Sorbye. (2017) Results after surgical treatment of liver metastases in patients with high-grade gastroenteropancreatic neuroendocrine carcinomas. European Journal of Surgical Oncology 43:9, pages 1682-1689.
Crossref
Crossref
Tingting Li, Man Lu, Jun Song, Ping Wu, Xueqing Cheng & Zhenqi Zhang. (2017) Improvement to ultrasonographical differential diagnosis of gastric lesions: The value of contrast enhanced sonography with gastric distention. PLOS ONE 12:8, pages e0182332.
Crossref
Crossref
Jan P Dumanski, Chiara Rasi, Peyman Björklund, Hanna Davies, Abir S Ali, Malin Grönberg, Staffan Welin, Halfdan Sorbye, Henning Grønbæk, Janet L Cunningham, Lars A Forsberg, Lars Lind, Erik Ingelsson, Peter Stålberg, Per Hellman & Eva Tiensuu Janson. (2017) A MUTYH germline mutation is associated with small intestinal neuroendocrine tumors. Endocrine-Related Cancer 24:8, pages 427-443.
Crossref
Crossref
David S Rickman, Himisha Beltran, Francesca Demichelis & Mark A Rubin. (2017) Biology and evolution of poorly differentiated neuroendocrine tumors. Nature Medicine 23:6, pages 664-673.
Crossref
Crossref
Jie Li, Ming Lu, Zhihao Lu, Zhongwu Li, Yiqiang Liu, Li Yang, Jian Li, Xiaotian Zhang, Jun Zhou, Xicheng Wang, Jifang Gong, Jing Gao, Yan Li & Lin Shen. (2016) Irinotecan plus cisplatin followed by octreotide long-acting release maintenance treatment in advanced gastroenteropancreatic neuroendocrine carcinoma: IPO-NEC study. Oncotarget 8:15, pages 25669-25678.
Crossref
Crossref
Ville Sallinen, Tessa Y.S. Le Large, Shamil Galeev, Zahar Kovalenko, Elke Tieftrunk, Raphael Araujo, Güralp O. Ceyhan & Sebastien Gaujoux. (2017) Surveillance strategy for small asymptomatic non-functional pancreatic neuroendocrine tumors – a systematic review and meta-analysis. HPB 19:4, pages 310-320.
Crossref
Crossref
. 2017. Diagnostic Pathology: Hepatobiliary and Pancreas. Diagnostic Pathology: Hepatobiliary and Pancreas
408
411
.
Frank Pfeffer. 2017. Minimalinvasive Viszeralchirurgie. Minimalinvasive Viszeralchirurgie
349
360
.
Camilla B. Johnbeck, Ulrich Knigge, Seppo W. Langer, Annika Loft, Anne Kiil Berthelsen, Birgitte Federspiel, Tina Binderup & Andreas Kjaer. (2016)
Prognostic Value of
18
F-FLT PET in Patients with Neuroendocrine Neoplasms: A Prospective Head-to-Head Comparison with
18
F-FDG PET and Ki-67 in 100 Patients
. Journal of Nuclear Medicine 57:12, pages 1851-1857.
Crossref
Crossref
Yugang Cheng, Hanxiang Zhan, Lei Wang, Jianwei Xu, Guangyong Zhang, Zongli Zhang & Sanyuan Hu. (2016) Analysis of 100 consecutive cases of resectable pancreatic neuroendocrine neoplasms: clinicopathological characteristics and long-term outcomes. Frontiers of Medicine 10:4, pages 444-450.
Crossref
Crossref
Fanny Söderquist, Eva Tiensuu Janson, Annica J. Rasmusson, Abir Ali, Mats Stridsberg & Janet L. Cunningham. (2016) Melatonin Immunoreactivity in Malignant Small Intestinal Neuroendocrine Tumours. PLOS ONE 11:10, pages e0164354.
Crossref
Crossref
Marcela S Cavalcanti, Mithat Gönen & David S Klimstra. (2016) The ENETS/WHO grading system for neuroendocrine neoplasms of the gastroenteropancreatic system: a review of the current state, limitations and proposals for modifications. International Journal of Endocrine Oncology 3:3, pages 203-219.
Crossref
Crossref
Samuel J. Klempner, Bruce Gershenhorn, Phu Tran, Thomas K. Lee, Mark G. Erlander, Kyle Gowen, Alexa B. Schrock, Deborah Morosini, Jeffrey S. Ross, Vincent A. Miller, Philip J. Stephens, Sai-Hong Ignatius Ou & Siraj M. Ali. (2016)
BRAF
V600E Mutations in High-Grade Colorectal Neuroendocrine Tumors May Predict Responsiveness to BRAF–MEK Combination Therapy
. Cancer Discovery 6:6, pages 594-600.
Crossref
Crossref
Bruno Conte, Ben George, Michael Overman, Jeannelyn Estrella, Zhi-Qin Jiang, Amir Mehrvarz Sarshekeh, Renata Ferrarotto, Paulo M. Hoff, Asif Rashid, James C. Yao, Scott Kopetz & Arvind Dasari. (2016) High-Grade Neuroendocrine Colorectal Carcinomas: A Retrospective Study of 100 Patients. Clinical Colorectal Cancer 15:2, pages e1-e7.
Crossref
Crossref
Sven-Petter Haugvik, Daniel Kaemmerer, Sebastien Gaujoux, Knut Jørgen Labori, Caroline Sophie Verbeke & Ivar Prydz Gladhaug. (2016) Pathology and Surgical Treatment of High-Grade Pancreatic Neuroendocrine Carcinoma: an Evolving Landscape. Current Oncology Reports 18:5.
Crossref
Crossref
Tine Gregersen, Christina Brock, Anne-Mette Haase, Søren Laurberg, Asbjørn M Drewes, Henning Grønbæk & Klaus Krogh. (2016) Rectal Mechano-sensory Function in Patients with Carcinoid Diarrhea. Journal of Neurogastroenterology and Motility 22:2, pages 264-271.
Crossref
Crossref
A. G. Krieger, A. V. Smirnov, S. V. Berelavichus, D. S. Gorin, A. R. Kaldarov, N. A. Karel’skaya, N. N. Vetsheva, D. V. Kalinin, A. N. Lebedeva & R. S. Dugarova. (2016) Organic hyperinsulinism: radiological diagnostics and surgical treatment. Khirurgiya. Zhurnal im. N.I. Pirogova:6, pages 14.
Crossref
Crossref
Iben Engelund Luna, Nina Monrad, Tina Binderup, Christina Boisen Thoegersen, Linda Hilsted, Claus Jensen, Birgitte Federspiel & Ulrich Knigge. (2016) Somatostatin-Immunoreactive Pancreaticoduodenal Neuroendocrine Neoplasms: Twenty-Three Cases Evaluated according to the WHO 2010 Classification. Neuroendocrinology 103:5, pages 567-577.
Crossref
Crossref
Mohammad Murad Kasim Kadhim, Marie Louise Jespersen, Hans Kristian Pilegaard, Marianne Nordsmark & Gerda Elisabeth Villadsen. (2016) Mixed Adenoneuroendocrine Carcinoma Is a Rare but Important Tumour Found in the Oesophagus. Case Reports in Gastrointestinal Medicine 2016, pages 1-3.
Crossref
Crossref
Ville Sallinen, Caj Haglund & Hanna Seppänen. (2015) Outcomes of resected nonfunctional pancreatic neuroendocrine tumors: Do size and symptoms matter?. Surgery 158:6, pages 1556-1563.
Crossref
Crossref
T. J. Musholt & F. M. Watzka. (2015) Neuroendokrine Neoplasien des gastroenteropankreatischen SystemsGastroenteropancreatic neuroendocrine neoplasms. Der Gastroenterologe 10:5, pages 410-417.
Crossref
Crossref
Irina Velikyan. (2015) 68Ga-Based Radiopharmaceuticals: Production and Application Relationship. Molecules 20:7, pages 12913-12943.
Crossref
Crossref
Tine Gregersen, Anne-Mette Haase, Vincent Schlageter, Henning Gronbaek & Klaus Krogh. (2015) Regional Gastrointestinal Transit Times in Patients With Carcinoid Diarrhea: Assessment With the Novel 3D-Transit System. Journal of Neurogastroenterology and Motility 21:3, pages 423-432.
Crossref
Crossref
Andreas Pfeifer, Ulrich Knigge, Tina Binderup, Jann Mortensen, Peter Oturai, Annika Loft, Anne Kiil Berthelsen, Seppo W. Langer, Palle Rasmussen, Dennis Elema, Eric von Benzon, Liselotte Højgaard & Andreas Kjaer. (2015)
64
Cu-DOTATATE PET for Neuroendocrine Tumors: A Prospective Head-to-Head Comparison with
111
In-DTPA-Octreotide in 112 Patients
. Journal of Nuclear Medicine 56:6, pages 847-854.
Crossref
Crossref
Emma Ilett, Seppo Langer, Ingrid Olsen, Birgitte Federspiel, Andreas Kjær & Ulrich Knigge. (2015) Neuroendocrine Carcinomas of the Gastroenteropancreatic System: A Comprehensive Review. Diagnostics 5:2, pages 119-176.
Crossref
Crossref
Ingrid Holst Olsen, Nanna Holt, Seppo W. Langer, Jane P. Hasselby, Henning Grønbæk, Jens Hillingsø, Masti Mahmoud, Morten Ladekarl, Lene H. Iversen, Andreas Kjær, Birgitte H. Federspiel & Ulrich Knigge. (2015) Goblet Cell Carcinoids: Characteristics of a Danish Cohort of 83 Patients. PLOS ONE 10:2, pages e0117627.
Crossref
Crossref